Skip to main content

Closed

JAGX: Jaguar Health, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-1.5% / yr

Operating margin-86.3%

ROIC-89.3%

Financially safe

Stretched

Debt / equity-3.09×

Interest coverage-36.2×

Current ratio0.50×

Jaguar Health, Inc.

JAGXNASDAQ Capital Market·USD·Closed

Jaguar Health, Inc.

JAGXNASDAQ·USD·Closed

$1.00

−3.85%

$1.00

−$0.04 (3.85%)

52W Range

0thpctl

Volume

0.29×avg

Mkt Cap

66640USD

P/E

-0.0TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.29×avg

Market Cap

66640USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings